Study resurrects Merck’s hopes for Keytruda in breast cancerJust a few weeks ago Merck & Co was lamenting a failed trial for Keytruda in triple-negative breast Share XStudy resurrects Merck’s hopes for Keytruda in breast cancerhttps://pharmaphorum.com/news/study-resurrects-mercks-hopes-for-keytruda-in-breast-cancer/
Merck gets FDA nod for new antibiotic, but says use with careThe FDA has approved a new triple-drug antibiotic from Merck & Co, but the company and regulator have Share XMerck gets FDA nod for new antibiotic, but says use with carehttps://pharmaphorum.com/news/merck-gets-fda-nod-for-new-antibiotic-but-says-use-with-care/
Merck claims a brace of head and neck cancer approvalsMerck & Co/MSD has done the double in head and neck cancer with a pair of FDA approvals Share XMerck claims a brace of head and neck cancer approvalshttps://pharmaphorum.com/news/merck-claims-a-brace-of-head-and-neck-cancer-approvals/
